L

Lovenox

A $120 million settlement was reached for those who indirectly purchased Lovenox or its generic equivalent enoxaparin.

ClosedUnited States-wideClaim status: Claim window closedPayout: Closed settlementNo longer claimable

About this settlement

Class action settlement for consumers who indirectly purchased Lovenox or enoxaparin due to alleged price-fixing.

This settlement resolves claims related to alleged price-fixing of the blood thinner Lovenox and its generic equivalent enoxaparin. Eligible claimants who indirectly purchased these drugs may have received compensation from the $120 million fund.

Who qualifies

  • Individuals who indirectly purchased Lovenox or enoxaparin.
  • Purchases related to the price-fixing period covered by the settlement.

Closed settlement

Claim status: Claim window closed

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon